CAS |
Chemical Name |
Cat.No. |
MolFormula |
27631-29-4 |
Quinazoline, 2,4-dichloro-6,7-dimethoxy- |
ABP010987 |
C10H8Cl2N2O2 |
28597-08-2 |
Pyridine, 3,4,5-trichloro-2,6-dimethyl- |
ABP010921 |
C7H6Cl3N |
25391-60-0 |
Pyridine, 2-chloro-3-iodo-5-nitro- |
ABP010920 |
C5H2ClIN2O2 |
210095-58-2 |
Pyridine, 2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)Methyl]-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) |
ABP010915 |
C21H25ClN2O7 |
201594-84-5 |
Pyridine, 2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]- |
ABP010914 |
C17H19ClN2O |
2078-54-8 |
Propofol |
ABP010861 |
C12H18O |
21339-47-9 |
Propanedioic acid, 2-(2,2-diethoxyethyl)-, 1,3-diethyl ester |
ABP010843 |
C13H24O6 |
253324-50-4 |
Propanamide, 2-amino-N-[(7S)-6,7-dihydro-5-methyl-6-oxo-5H-dibenz[b,d]azepin-7-yl]-,(2S)- |
ABP010835 |
|
23288-49-5 |
Probucol |
ABP010826 |
C31H48O2S2 |
2542-99-6 |
Pregn-20-yne-3,17-diol, (3α,5β,17α)- |
ABP010819 |
C21H32O2 |
202350-68-3 |
PNU-159682 |
ABP010772 |
|
2492-87-7 |
PNPG |
ABP010767 |
C12H15NO8.H2O |
29868-97-1 |
Pirenzepine (dihydrochloride) |
ABP010732 |
C19H21N5O2.2ClH |
206983-57-5 |
Pifithrin-M |
ABP010701 |
|
22895-28-9 |
Phthalic acid, 3,3'-azoxydi- (8CI) |
ABP010685 |
C16H10N2O9 |
200636-54-0 |
Phosphine oxide, [(2Z)-2-[(3R,4R,5R)-3,5-bis[[(1,1-diMethylethyl)diMethylsilyl]oxy]-4-[3-[[(1,1-diMethylethyl)diMethylsilyl]oxy]propoxy]-2-Methylenecyclohexylidene]ethyl]diphenyl- |
ABP010673 |
C42H71O5PSi3 |
221670-72-0 |
Phenol, 4-[(1S)-1-aminoethyl]- |
ABP010652 |
C8H11NO |
250214-69-8 |
Phenol, 2-[3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-(methoxymethyl)- |
ABP010638 |
C23H33NO2 |
254750-83-9 |
Pentanoic acid, 3-[[(2S)-2-[[2-[[2-(1,1-dimethylethyl)phenyl]amino]-2-oxoacetyl]amino]-1-oxopropyl]amino]-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)-, 1,1-dimethylethyl ester, (3S)- |
ABP010563 |
C30H35F4N3O7 |
243982-55-0 |
PDHK inhibitor |
ABP010541 |
|
20554-84-1 |
Parthenolide |
ABP010515 |
C15H20O3 |
217797-14-3 |
Paroxetine (Mesylate) |
ABP010514 |
|
27113-22-0 |
Paradol |
ABP010505 |
C17H26O3 |